UBS Group’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

UBS Group’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-387	Closed	-$4.2K	–	11472
2022 Q4	$4.2K	Buy	+387	New	+$4K	﹤0.01%	9366

UBS Group's ARCK Position: Q1 2023 in Review

UBS Group sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q1 2023, closing a stake of 387 shares — an estimated $4.2K sold.

UBS Group first reported a position in ARCK in Q4 2022 and held it in 1 quarter. The position peaked at $4.2K in Q4 2022. 1 fund tracked by Wall St. Rank holds ARCK as of Q1 2023.

UBS Group reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q1 2023 after selling out during the quarter.
UBS Group sold 387 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q1 2023, an estimated $4.2K.
UBS Group first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2022 and held it in 1 quarter.
UBS Group's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $4.2K in Q4 2022.
1 fund tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.